D. R. Higgs, W. G. Wood, C. Barton, and D. J. Weatherall, Clinical features and molecular analysis of acquired hemoglobin H disease, Am J Med, vol.75, pp.181-191, 1983.

R. J. Gibbons, A. Pellagatti, and D. Garrick, Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS), Nat Genet, vol.34, pp.446-449, 2003.

M. J. Law, K. M. Lower, and H. Voon, ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a sizedependent manner, Cell, vol.143, pp.367-378, 2010.

D. P. Steensma, D. R. Higgs, C. A. Fisher, and R. J. Gibbons, Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations, Blood, vol.103, pp.2019-2026, 2004.

D. P. Steensma, R. J. Gibbons, and D. R. Higgs, Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies, Blood, vol.105, pp.443-452, 2005.

E. Papaemmanuil, M. Gerstung, and L. Malcovati, Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, pp.3616-3627, 2013.

C. Herbaux, C. Badens, and S. Guidez, A new ATRX mutation in a patient with acquired athalassemia myelodysplastic syndrome, Hemoglobin, vol.36, pp.581-585, 2012.

C. Rose, M. Fournier, and O. Nibourel, Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): Evolution on hypomethylating agent therapy, Leuk Res, vol.35, pp.203-205, 2011.